Cardinal Health to acquire Integrated Oncology Network for $1.12 billion
Adds details and background throughout
Sept 20 (Reuters) - CardinalHealth CAH.N on Friday agreed to acquire community cancer center operator IntegratedOncology Network for $1.12 billion in cash, marking its expansion into cancer care.
The Dublin, Ohio-based company is the latest to join thetrend of healthcare service companies diversifying beyond drug distribution.
Rival McKesson MCK.N recently acquired a unit of Florida Cancer Specialists & Research Institute for $2.49 billion, while Cencora, in partnership with TPG Inc., purchased OneOncology for $2.1 billion in 2023.
The deal gives Cardinal Health's cancer-focused unit Navista access to a network of more than 100 healthcare providers across 10 states in the U.S.
As part of the agreement, Integrated Oncology Network's more than 50 practice sites will join Navista, which offers reimbursement services, management support, and various other services to community oncology practices.
"Since its 2023 investor day at which Navista was unveiled, Cardinal has talked about expanding its work with community practices, and we see today’s acquisition as providing a positive step in that direction in the oncology space," said J.P.Morgan analyst Lisa Gill.
Cardinal Health expects the transaction to be accretive to its profit 12 months after closing the deal.
Reporting by Sneha S K; Editing by Anil D'Silva and Tasim Zahid
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
